← Back
$STOK All transactions

Stoke Therapeutics, Inc.

M

$ Value

$0

Shares

10,000

Price

$0

Filed

Mar 17

Insider

Name

Hoitt Jason

Title

Chief Patient Officer

CIK

0001762572

Roles

Officer

Transaction Details

Transaction Date

2026-03-15

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

13,988

Footnotes

The reported total includes an aggregate 2,186 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d). | Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement. | The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date.

Filing Info

Accession No.

0001762572-26-000004

Form Type

4

Issuer CIK

0001623526

Hoitt Jason's History

Date Ticker Type Value
2026-03-18 STOK $55K
2026-03-18 STOK $4K
2026-03-18 STOK $986
2026-03-17 STOK $34K
2026-03-17 STOK $25K
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-02-17 STOK A $0
2026-02-17 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$147K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20